Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “United Kingdom”
- OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR AmyloidosisRecruiting
Sponsor: AstraZeneca
ATTR Amyloidosis
United States, Canada, China, Denmark, Germany +6 more
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, Argentina, Australia, Belgium, Brazil +12 more
- Long-Term Extension Study of Vosoritide to Treat Children With HypochondroplasiaEnrolling By Invitation
Sponsor: BioMarin Pharmaceutical
Hypochondroplasia
United States, Australia, Canada, France, Germany +4 more
- A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung CancerActive Not Recruiting
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Austria, Brazil, Bulgaria, Canada +20 more
- Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee ArthritisActive Not Recruiting
Sponsor: Invibio Ltd
Complete Questionnaires Following TKR Surgery
United Kingdom
Sponsor: Merck Sharp & Dohme LLC
Small Cell Lung Cancer
United States, Argentina, Australia, Chile, China +7 more
- First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell LymphomaActive Not Recruiting
Sponsor: Genmab
DLBCL · High-grade B-cell Lymphoma (HGBCL) · Primary Mediastinal Large B-cell Lymphoma (PMBCL) · FL
United States, Australia, Canada, Denmark, Finland +10 more
Sponsor: Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis · Diabetes Mellitus, Type 2
United States, Belgium, France, Netherlands, United Kingdom
- A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderRecruiting
Sponsor: Pfizer
Clostridoides Difficile Associated Disease
United States, Argentina, Japan, United Kingdom
- A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Duchenne Muscular Dystrophy
Belgium, France, Germany, Italy, Spain +1 more
Sponsor: Takeda
Von Willebrand Disease (VWD)
United States, France, Ireland, Italy, Japan +1 more
Sponsor: Eli Lilly and Company
Obesity
United Kingdom
Sponsor: RIGImmune Inc.
Healthy Adult Participants · Asthma Exacerbation · Safety and Efficacy
United Kingdom
Sponsor: Gilead Sciences
Triple Negative Breast Cancer
United States, Australia, Belgium, Brazil, France +6 more
Sponsor: Takeda
Psoriatic Arthritis
United States, Argentina, Australia, Brazil, Canada +7 more
Sponsor: Gold Standard Phantoms
Prostate Cancers
United Kingdom
Sponsor: Novartis Pharmaceuticals
Geographic Atrophy Secondary to Age-related Macular Degeneration
United States, Australia, Bulgaria, Canada, Colombia +11 more
Sponsor: Iambic Therapeutics, Inc
HER2 Mutation-Related Tumors · HER2 · HER2-positive Breast Cancer · HER2 + Breast Cancer
United States, France, Ireland, Italy, Netherlands +3 more
Sponsor: Celgene
Relapsed or Refractory Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +24 more
- A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic SclerosisRecruiting
Sponsor: Novartis Pharmaceuticals
Diffuse Cutaneous Systemic Sclerosis
United States, Argentina, Austria, Belgium, Brazil +20 more
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, Australia, Brazil, Bulgaria +10 more
Sponsor: EMD Serono Research & Development Institute, Inc.
Dermatomyositis · Polymyositis
United States, Czechia, Greece, Italy, Poland +2 more
Sponsor: AstraZeneca
Chronic Kidney Disease
United States, Argentina, Australia, Brazil, Bulgaria +32 more
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackActive Not Recruiting
Sponsor: Novo Nordisk A/S
Cardiovascular Risk · Acute Myocardial Infarction (AMI)
United States, Argentina, Australia, Brazil, Bulgaria +19 more
Sponsor: Swedish Orphan Biovitrum
C3 Glomerulopathy (C3G) · Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Australia, Austria, Belgium, Canada, Czechia +9 more